BELSOMRA 20 mg/1
suvorexant · TABLET, FILM COATED · Merck Sharp & Dohme LLC
Belsomra (suvorexant) is a prescription tablet taken by mouth to treat insomnia by blocking orexin receptors in the brain, which helps promote sleep. It comes in a 20 mg strength and belongs to a class of medications called orexin receptor antagonists.
Key Facts
- Brand Name
- BELSOMRA
- Generic Name
- suvorexant
- NDC Code (Product)
0006-0335- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 20 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule IV (Controlled)
- Application #
- NDA204569
- Drug Class
- Orexin Receptor Antagonist [EPC]
- Marketing Start
- 08/29/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is BELSOMRA used for?
Belsomra (suvorexant) is a prescription tablet taken by mouth to treat insomnia by blocking orexin receptors in the brain, which helps promote sleep. It comes in a 20 mg strength and belongs to a class of medications called orexin receptor antagonists.
Is BELSOMRA a controlled substance?
Yes, BELSOMRA is classified as CIV under the DEA Controlled Substances Act.
What is the generic name for BELSOMRA?
The generic name for BELSOMRA is suvorexant. There are no other listed brand versions of suvorexant.
What is the NDC code for BELSOMRA 20 mg/1?
The NDC (National Drug Code) for BELSOMRA 20 mg/1 is 0006-0335, listed by Merck Sharp & Dohme LLC.
Other BELSOMRA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)